ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.772,85
0,50%
S&P 500
5.223,21
0,18%
Dow Jones
39.526,32
0,35%
Euro vs US Dollar
1,07745
-0,06%
Bitcoin
60.673,40
-3,77%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. bluebird bio Inc (BLUE)

  7. bluebird bio Inc (BLUE) News

BLUE

bluebird bio (BLUE)

bluebird bio Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:BLUE
DatumZeitQuelleÜberschriftSymbolFirma
09/05/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BLUEbluebird bio Inc
09/05/202413h00Business Wirebluebird bio Reports First Quarter 2024 Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
07/05/202411h45PR Newswire (US)The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 28, 2024 in bluebird bio, Inc. Lawsuit - BLUENASDAQ:BLUEbluebird bio Inc
06/05/202413h05Business Wirebluebird bio Announces First Quarter 2024 Results Call Date and Upcoming Investor EventsNASDAQ:BLUEbluebird bio Inc
06/05/202413h00Business Wirebluebird bio Announces Completion of First Cell Collection for LYFGENIA™ Gene TherapyNASDAQ:BLUEbluebird bio Inc
03/05/202411h45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) - May 28, 2024 Deadline to Join - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
26/04/202422h05Business Wirebluebird bio Announces Receipt of Expected Notice from NasdaqNASDAQ:BLUEbluebird bio Inc
26/04/202411h45PR Newswire (US)BLUE LAWSUIT ALERT: The Gross Law Firm Notifies bluebird bio, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNASDAQ:BLUEbluebird bio Inc
19/04/202411h45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - BLUENASDAQ:BLUEbluebird bio Inc
16/04/202411h45PR Newswire (US)Class Action Filed Against bluebird bio, Inc. (BLUE) Seeking Recovery for Investors - Contact The Gross Law FirmNASDAQ:BLUEbluebird bio Inc
12/04/202411h45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) Urged to Join Class Action - Contact The Gross Law Firm to Learn MoreNASDAQ:BLUEbluebird bio Inc
11/04/202414h00Business Wirebluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:BLUEbluebird bio Inc
09/04/202411h45PR Newswire (US)bluebird bio, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before May 28, 2024 to Discuss Your Rights - BLUENASDAQ:BLUEbluebird bio Inc
05/04/202411h45PR Newswire (US)Shareholders that lost money on bluebird bio, Inc.(BLUE) should contact The Gross Law Firm about pending Class Action - BLUENASDAQ:BLUEbluebird bio Inc
26/03/202412h01Business Wirebluebird bio Reports Fourth Quarter and 2023 Annual Results and Highlights Operational Progress and 2024 GuidanceNASDAQ:BLUEbluebird bio Inc
25/03/202421h05Business Wirebluebird bio to Host Fourth Quarter and 2023 Annual Results Conference CallNASDAQ:BLUEbluebird bio Inc
18/03/202413h00Business Wirebluebird bio Secures up to $175 Million Debt Financing with Hercules CapitalNASDAQ:BLUEbluebird bio Inc
11/03/202413h00Business Wirebluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene TherapyNASDAQ:BLUEbluebird bio Inc
05/03/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
05/03/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
05/03/202423h40Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
05/03/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
05/03/202423h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
14/02/202419h54Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLUEbluebird bio Inc
06/02/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
06/02/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
06/02/202422h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
09/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
09/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BLUEbluebird bio Inc
08/01/202422h35Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BLUEbluebird bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLUE

Kürzlich von Ihnen besucht

TG
DTE
Deutsche Telekom
NYSE
MCD
McDonalds
USOTC
ADDYY
Adidas (QX)
CCOM
SILVER
SILVER
TG
D7G
Nel ASA
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
BASFY
BASF (QX)
FX
EURJPY
Euro vs Yen
CCOM
US100
US Tech 100
COIN
ETHUSD
Ethereum
TG
RHM
Rheinmetall
NYSE
XOM
Exxon Mobil
USOTC
RHHBY
Roche (QX)
AMEX
XLF
Financial Select Sector
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten